Histopathology of gastrointestinal neuroendocrine neoplasms

Frontiers in Oncology

Volumn 3 JAN, Issue , 2013, Pages

  Hirabayashi, Kenichi ^a,b   Zamboni, Giuseppe ^a,c   Nishi, Takayuki ^b   Tanaka, Akira ^b   Kajiwara, Hiroshi ^b   Nakamura, Naoya ^b  

^a SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Carcinoid; Gastrointestinal tract; Neuroendocrine carcinoma; Neuroendocrine marker; Neuroendocrine neoplasm

Indexed keywords

ARF PROTEIN; BETA CATENIN; CHROMOGRANIN A; CHROMOGRANIN B; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID RECEPTOR BETA; SYNAPTOPHYSIN; THROMBOSPONDIN 1;

APPENDIX CANCER; ASPIRATION CYTOLOGY; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; DIGESTIVE SYSTEM CANCER; DUODENUM CANCER; ESOPHAGUS CANCER; HISTOPATHOLOGY; HUMAN; ILEUM CANCER; IMMUNOHISTOCHEMISTRY; JEJUNUM CANCER; MITOSIS INDEX; NEUROENDOCRINE TUMOR; PROTEIN EXPRESSION; RECTUM CANCER; REVIEW; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; TUMOR BIOPSY;

EID: 84890129888     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00002     Document Type: Review

References (82)

1. Acs, G., McGrath, C. M., and Gupta, P. K. (2000). Duodenal carcinoid tumor: report of a case diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy with immunocytochemical correlation. Diagn. Cytopathol. 23, 183-186.
2. Al-Khafaji, B., Noffsinger, A. E., Miller, M. A., Devoe, G., Stemmermann, G. N., and Fenoglio-Preiser, C. (1998). Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors. Hum. Pathol. 29, 992-999.
3. Alsaad, K. O., Serra, S., Schmitt, A., Perren, A., and Chetty, R. (2007). Cytokeratins 7 and 20 immunoexpression profile in goblet cell and classical carcinoids of appendix. Endocr. Pathol. 18, 16-22.
4. Anlauf, M., Perren, A., Meyer, C. L., Schmid, S., Saremaslani, P., Kruse, M. L., et al. (2005). Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas. Gastroenterology 128, 1187-1198.
5. Arnason, T., Sapp, H. L., Barnes, P. J., Drewniak, M., Abdolell, M., and Rayson, D. (2011a). Immunohistochemical expression and prognostic value of ER, PR and HER2/neu in pancreatic and small intestinal neuroendocrine tumors. Neuroendocrinology 93, 249-258.
6. Arnason, T., Sapp, H. L., Rayson, D., Barnes, P. J., Drewniak, M., Nassar, B. A., et al. (2011b). Loss of expression of DNA mismatch repair proteins is rare in pancreatic and small intestinal neuroendocrine tumors. Arch. Pathol. Lab. Med. 135, 1539-1544.
7. Arnold, C. N., Sosnowski, A., Schmitt-Graff, A., Arnold, R., and Blum, H. E. (2007). Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system. Int. J. Cancer 120, 2157-2164.
8. Azzoni, C., Bottarelli, L., Cecchini, S., Lagrasta, C., Pizzi, S., D'Adda, T., et al. (2011). Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors. Virchows Arch. 458, 525-536.
9. Benya, R. V., Metz, D. C., Hijazi, Y. J., Fishbeyn, V. A., Pisegna, J. R., and Jensen, R. T. (1993). Fine needle aspiration cytology of submucosal nodules in patients with Zollinger-Ellison syndrome. Am. J. Gastroenterol. 88, 258-265.
10. Bibeau, F., Chateau, M. C., Guiu, M., Assenat, E., Azria, D., Lavaill, R., et al. (2008). Small cell carcinoma with concomitant adenocarcinoma arising in a Barrett's oesophagus: report of a case with a favourable behaviour. Virchows Arch. 452, 103-107.
11. Bosman, F. T., Organization, W. H., and Cancer, I. A. F. R. O. (2010). WHO Classification of Tumours of the Digestive System. Lyon: International Agency for Research on Cancer. Brenner, B., Tang, L. H., Klimstra, D. S., and Kelsen, D. P. (2004). Small-cell carcinomas of the gastrointestinal tract: a review. J. Clin. Oncol. 22, 2730-2739.
12. Burke, A. P., Thomas, R. M., Elsayed, A. M., and Sobin, L. H. (1997). Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases. Cancer 79, 1086-1093.
13. Carr, N. J., and Sobin, L. H. (2004). Neuroendocrine tumors of the appendix. Semin. Diagn. Pathol. 21, 108-119.
14. Chan, A. O., Kim, S. G., Bedeir, A., Issa, J. P., Hamilton, S. R., and Rashid, A. (2003). CpG island methylation in carcinoid and pancreatic endocrine tumors. Oncogene 22, 924-934.
15. Chen, K. T. (2000). Cytology of small-cell carcinoma arising in Barrett's esophagus. Diagn. Cytopathol. 23, 180-182.
16. Couvelard, A., Deschamps, L., Ravaud, P., Baron, G., Sauvanet, A., Hentic, O., et al. (2009). Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors. Mod. Pathol. 22, 273-281.
17. Duerr, E. M., Mizukami, Y., Ng, A., Xavier, R. J., Kikuchi, H., Deshpande, V., et al. (2008). Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis. Endocr. Relat. Cancer 15, 243-256.
18. Evers, B. M., Rady, P. L., Tyring, S. K., Sanchez, R. L., Rajaraman, S., Townsend, C. M. Jr., et al. (1992). Amplification of the HER-2/neu protooncogene in human endocrine tumors. Surgery 112, 211-217. discussion: 217-218.
19. Federspiel, B. H., Burke, A. P., Sobin, L. H., and Shekitka, K. M. (1990). Rectal and colonic carcinoids. A clinicopathologic study of 84 cases. Cancer 65, 135-140.
20. Fujimori, M., Ikeda, S., Shimizu, Y., Okajima, M., and Asahara, T. (2001). Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor. Cancer Res. 61, 6656-6659.
21. Garbrecht, N., Anlauf, M., Schmitt, A., Henopp, T., Sipos, B., Raffel, A., et al. (2008). Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity. Endocr. Relat. Cancer 15, 229-241.
22. Gould, V. E., Lee, I., Wiedenmann, B., Moll, R., Chejfec, G., and Franke, W. W. (1986). Synaptophysin: a novel marker for neurons, certain neuroendocrine cells, and their neoplasms. Hum. Pathol. 17, 979-983.
23. Hirabayashi, K., Yasuda, M., Osamura, R. Y., Hirasawa, T., and Murakami, M. (2006). Ovarian nongestational choriocarcinoma mixed with various epithelial malignancies in association with endometriosis. Gynecol. Oncol. 102, 111-117.
24. Hoang, M. P., Hobbs, C. M., Sobin, L. H., and Albores-Saavedra, J. (2002). Carcinoid tumor of the esophagus: a clinicopathologic study of four cases. Am. J. Surg. Pathol. 26, 517-522.
25. Hoda, S. A., and Hajdu, S. I. (1992). Small cell carcinoma of the esophagus. Cytology and immunohistology in four cases. Acta Cytol. 36, 113-120.
26. Kajiwara, H., Hirabayashi, K., Miyazawa, M., Nakamura, N., Hirasawa, T., Muramatsu, T., et al. (2009). Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine carcinoma of uterine cervix. Arch. Gynecol. Obstet. 279, 521-525.
27. Kidd, M., Eick, G., Shapiro, M. D., Camp, R. L., Mane, S. M., and Modlin, I. M. (2005). Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors. Cancer 103, 229-236.
28. Kloppel, G., Perren, A., and Heitz, P. U. (2004). The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann. N.Y. Acad. Sci. 1014, 13-27.
29. Kloppel, G., Rindi, G., Anlauf, M., Perren, A., and Komminoth, P. (2007). Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Arch. 451(Suppl.1), S9-S27.
30. Kloppel, G., Rindi, G., Perren, A., Komminoth, P., and Klimstra, D. S. (2010). The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Arch. 456, 595-597.
31. La Rosa, S., Inzani, F., Vanoli, A., Klersy, C., Dainese, L., Rindi, G., et al. (2011). Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms. Hum. Pathol. 42, 1373-1384.
32. Levy, A. D., and Sobin, L. H. (2007). From the archives of the AFIP: gastrointestinal carcinoids: imaging features with clinicopathologic comparison. Radiographics 27, 237-257.
33. Liszka, L., Pajak, J., Mrowiec, S., Zielinska-Pajak, E., Golka, D., and Lampe, P. (2011). Discrepancies between two alternative staging systems (European Neuroendocrine Tumor Society 2006 and American Joint Committee on Cancer/Union for International Cancer Control 2010) of neuroendocrine neoplasms of the pancreas. A study of 50 cases. Pathol. Res. Pract. 207, 220-224.
34. Liu, L., Broaddus, R. R., Yao, J. C., Xie, S., White, J. A., Wu, T. T., et al. (2005). Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis. Mod. Pathol. 18, 1632-1640.
35. Lloyd, R. V. (2003). Practical markers used in the diagnosis of neuroendocrine tumors. Endocr. Pathol. 14, 293-301.
36. Lollgen, R. M., Hessman, O., Szabo, E., Westin, G., and Akerstrom, G. (2001). Chromosome 18 deletions are common events in classical midgut carcinoid tumors. Int. J. Cancer 92, 812-815.
37. Nassar, H., Albores-Saavedra, J., and Klimstra, D. S. (2005). High-grade neuroendocrine carcinoma of the ampulla of vater: a clinicopathologic and immunohistochemical analysis of 14 cases. Am. J. Surg. Pathol. 29, 588-594.
38. Ordonez, N. G. (2000). Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am. J. Surg. Pathol. 24, 1217-1223.
39. Pape, U. F., Jann, H., Muller-Nordhorn, J., Bockelbrink, A., Berndt, U., Willich, S. N., et al. (2008). Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113, 256-265.
40. Perren, A., Schmid, S., Locher, T., Saremaslani, P., Bonvin, C., Heitz, P. U., et al. (2004). BRAF and endocrine tumors: mutations are frequent in papillary thyroid carcinomas, rare in endocrine tumors of the gastrointestinal tract and not detected in other endocrine tumors. Endocr. Relat. Cancer 11, 855-860.
41. Pizzi, S., Azzoni, C., Bassi, D., Bottarelli, L., Milione, M., and Bordi, C. (2003). Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract. Cancer 98, 1273-1282.
42. Pizzi, S., Azzoni, C., Bottarelli, L., Campanini, N., D'Adda, T., Pasquali, C., et al. (2005). RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours. J. Pathol. 206, 409-416.
43. Ramnani, D. M., Wistuba, I. I., Behrens, C., Gazdar, A. F., Sobin, L. H., and Albores-Saavedra, J. (1999). K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix. Cancer 86, 14-21.
44. Rindi, G., Azzoni, C., La Rosa, S., Klersy, C., Paolotti, D., Rappel, S., et al. (1999). ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 116, 532-542.
45. Rindi, G., and Bordi, C. (2005). Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics. Best Pract. Res. Clin. Gastroenterol. 19, 519-534.
46. Rindi, G., Kloppel, G., Alhman, H., Caplin, M., Couvelard, A., De Herder, W. W., et al. (2006). TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 449, 395-401.
47. Rindi, G., Kloppel, G., Couvelard, A., Komminoth, P., Korner, M., Lopes, J. M., et al. (2007). TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 451, 757-762.
48. Rindi, G., Luinetti, O., Cornaggia, M., Capella, C., and Solcia, E. (1993). Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 104, 994-1006.
49. Rindi, G., Paolotti, D., Fiocca, R., Wiedenmann, B., Henry, J. P., and Solcia, E. (2000a). Vesicular monoamine transporter 2 as a marker of gastric enterochromaffin-like cell tumors. Virchows Arch. 436, 217-223.
50. Rindi, G., Villanacci, V., and Ubiali, A. (2000b). Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors. Digestion 62(Suppl. 1), 19-26.
51. Roy, P., and Chetty, R. (2010). Goblet cell carcinoid tumors of the appendix: an overview. World J. Gastrointest. Oncol. 2, 251-258.
52. Scherubl, H., Cadiot, G., Jensen, R. T., Rosch, T., Stolzel, U., and Kloppel, G. (2010). Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy 42, 664-671.
53. Semba, S., Kusumi, R., Moriya, T., and Sasano, H. (2000). Nuclear accumulation of B-catenin in human endocrine tumors: association with Ki-67 (MIB-1) proliferative activity. Endocr. Pathol. 11, 243-250.
54. Serrano, J., Goebel, S. U., Peghini, P. L., Lubensky, I. A., Gibril, F., and Jensen, R. T. (2000). Alterations in the p16INK4a/CDKN2A tumor suppressor gene in gastrinomas. J. Clin. Endocrinol. Metab. 85, 4146-4156.
55. Shia, J., Tang, L. H., Weiser, M. R., Brenner, B., Adsay, N. V., Stelow, E. B., et al. (2008). Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am. J. Surg. Pathol. 32, 719-731.
56. Shim, K. N., Yang, S. K., Myung, S. J., Chang, H. S., Jung, S. A., Choe, J. W., et al. (2004). Atypical endoscopic features of rectal carcinoids. Endoscopy 36, 313-316.
57. Sobin, L., Gospodarowicz, M., and Wittekind, C. (eds.). (2009). UICC: TNM Classification of Malignant Tumours. Oxford: Wiley-Blackwell.
58. Soga, J. (1998). Carcinoids of the colon and ileocecal region: a statistical evaluation of 363 cases collected from the literature. J. Exp. Clin. Cancer Res. 17, 139-148.
59. Soga, J., and Yakuwa, Y. (1999). Somatostatinoma/inhibitory syndrome: a statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas. J. Exp. Clin. Cancer Res. 18, 13-22.
60. Stancu, M., Wu, T. T., Wallace, C., Houlihan, P. S., Hamilton, S. R., and Rashid, A. (2003). Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors. Mod. Pathol. 16, 1189-1198.
61. Stelow, E. B., Moskaluk, C. A., and Mills, S. E. (2006). The mismatch repair protein status of colorectal small cell neuroendocrine carcinomas. Am. J. Surg. Pathol. 30, 1401-1404.
62. Stojsic, Z., Brasanac, D., Bilanovic, D., Mitrovic, O., Stevanovic, R., and Boricic, I. (2010). Large-cell neuroendocrine carcinoma of the ampulla of Vater. Med. Oncol. 27, 1144-1148.
63. Su, M. C., Wang, C. C., Chen, C. C., Hu, R. H., Wang, T. H., Kao, H. L., et al. (2006). Nuclear translocation of beta-catenin protein but absence of beta-catenin and APC mutation in gastrointestinal carcinoid tumor. Ann. Surg. Oncol. 13, 1604-1609.
64. Tang, L. H., Shia, J., Soslow, R. A., Dhall, D., Wong, W. D., O'Reilly, E., et al. (2008). Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am. J. Surg. Pathol. 32, 1429-1443.
65. Tasso, D. M., Attam, R., Aslan, D. L., and Pambuccian, S. E. (2012). Endoscopic ultrasound guided fine-needle aspiration diagnosis of duodenal high grade neuroendocrine carcinoma underlying a villous adenoma: report of a case. Diagn. Cytopathol. 40, 62-68.
66. Terris, B., Meddeb, M., Marchio, A., Danglot, G., Flejou, J. F., Belghiti, J., et al. (1998). Comparative genomic hybridization analysis of sporadic neuroendocrine tumors of the digestive system. Genes Chromosomes Cancer 22, 50-56.
67. Tsuda, H., Akiyama, F., Kurosumi, M., Sakamoto, G., Yamashiro, K., Oyama, T., et al. (2000). Evaluation of the interobserver agreement in the number of mitotic figures of breast carcinoma as simulation of quality monitoring in the Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol. Jpn. J. Cancer Res. 91, 451-457.
68. Van Eeden, S., Offerhaus, G. J., Hart, A. A., Boerrigter, L., Nederlof, P. M., Porter, E., et al. (2007). Goblet cell carcinoid of the appendix: a specific type of carcinoma. Histopathology 51, 763-773.
69. Wang, D. G., Johnston, C. F., and Buchanan, K. D. (1997). Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis. Cancer 80, 668-675.
70. Wang, G. G., Yao, J. C., Worah, S., White, J. A., Luna, R., Wu, T. T., et al. (2005). Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors. Mod. Pathol. 18, 1079-1087.
71. Wilson, B. S., and Lloyd, R. V. (1984). Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am. J. Pathol. 115, 458-468.
72. Yamaguchi, M., Hirose, K., and Hirai, N. (2007). HER2 expression in gastrointestinal carcinoid tumors: high in intestinal but not in gastric tumors. Surg. Today 37, 270-271.
73. Yamamoto, J., Ohshima, K., Ikeda, S., Iwashita, A., and Kikuchi, M. (2003). Primary esophageal small cell carcinoma with concomitant invasive squamous cell carcinoma or carcinoma in situ. Hum. Pathol. 34, 1108-1115.
74. Yang, Z., Tang, L. H., and Klimstra, D. S. (2011). Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification. Am. J. Surg. Pathol. 35, 853-860.
75. Yantiss, R. K., Odze, R. D., Farraye, F. A., and Rosenberg, A. E. (2003). Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases. Am. J. Surg. Pathol. 27, 811-817.
76. Yazawa, N., Imaizumi, T., Okada, K., Matsuyama, M., Dowaki, S., Tobita, K., et al. (2011). Nonfunctioning pancreatic endocrine tumor with extension into the main pancreatic duct: report of a case. Surg. Today 41, 737-740.
77. Yong, J., Huawei, L., Hu, L., Yingying, Y., Dianying, L., and Xiuhui, Z. (2010). Goblet cell carcinoid of the appendix: a clinicopathological and immunohistochemical study of 26 cases from southwest china. Int. J. Surg. Pathol. 18, 488-492.
78. Younes, N., Fulton, N., Tanaka, R., Wayne, J., Straus, F. H. 2nd., and Kaplan, E. L. (1997). The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors. Cancer 79, 1804-1808.
79. Yun, J. P., Zhang, M. F., Hou, J. H., Tian, Q. H., Fu, J., Liang, X. M., et al. (2007). Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases. BMC Cancer 7:38. doi: 10.1186/1471-2407-7-38
80. Zamboni, G., Franzin, G., Bonetti, F., Scarpa, A., Chilosi, M., Colombari, R., et al. (1990). Small-cell neuroendocrine carcinoma of the ampullary region. A clinicopathologic, immunohistochemical, and ultrastructural study of three cases. Am. J. Surg. Pathol. 14, 703-713.
81. Zhang, H. Y., Rumilla, K. M., Jin, L., Nakamura, N., Stilling, G. A., Ruebel, K. H., et al. (2006). Association of DNA methylation and epigenetic inactivation of RASSF1A and beta-catenin with metastasis in small bowel carcinoid tumors. Endocrine 30, 299-306.
82. Zhao, J., De Krijger, R. R., Meier, D., Speel, E. J., Saremaslani, P., Muletta-Feurer, S., et al. (2000). Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors (carcinoids): marked differences indicating diversity in molecular pathogenesis. Am. J. Pathol. 157, 1431-1438.